Technology | Cardiac PACS | March 09, 2018

Siemens Healthineers Launches Next Generation of syngo Dynamics at ACC 2018

Newest version of cardiovascular imaging and information system emphasizes enhanced security, widespread access, enterprise consistency and structure reporting

Siemens Healthineers Launches Next Generation of syngo Dynamics at ACC 2018

March 9, 2018 — At the American College of Cardiology’s 67th Annual Scientific Session and Expo, March 10-12 in Orlando, Fla., Siemens Healthineers launched the next generation of syngo Dynamics, a cardiovascular imaging and information solution. The newest version of the software emphasizes enhanced security, widespread access, enterprise consistency and structured reporting.

Siemens Healthineers developed the next generation of syngo Dynamics with enhanced security features and improved workflow capabilities that enable both fast and secure readings from any location. Now HTML 5-enabled, syngo Dynamics can be accessed remotely with a common worklist on a variety of platforms, allowing users to access images across imaging modalities on any device. This single point of access ensures that all data is included in one place and available to users at a glance.

In addition, syngo Dynamics offers healthcare organizations consistency throughout their enterprises. The technology can be deployed easily and efficiently, launching the syngo Dynamics software in every hospital within a healthcare system at once. This enterprise-wide approach also enables faster and easier system upgrades.

The software enables fast, precise and smart structured reporting with customizable reports and worksheets that auto-populates measurements, calculations and observational data. The new version of syngo Dynamics comes equipped with intuitive and streamlined tools for reading and reporting such as an all new measurement and calculation palette.

For more information: www.usa.healthcare.siemens.com

 

Related Content

A patient who received HeartMate III LVAD system at ACC.18. The HeartMate 3 was the topic of of the the key late-breaking trials at #ACC18

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC.18. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at this year's conference.

Feature | ACC | March 27, 2018 | Dave Fornell
There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American Colle
Drug Stops Dangerous Bleeding in Patients Taking Factor Xa Inhibitors

Connolly 

News | ACC | March 22, 2018
March 22, 2018 — The experimental drug...
Videos | ACC | March 21, 2018
DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at
ACC 2018 Late-Breaking Trials Announced
News | ACC | March 21, 2018
Here is a list of the American College of Cardiology (ACC) 2018 annual meeting late-breaking clinical trials presente
Inhaled Therapy Ineffective in Difficult-to-Treat Heart Failure at ACC 2018.

Image from presentation, "Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF: The INDIE-HFpEF Trial," Borlaug

News | ACC | March 20, 2018
March 20, 2018 — Four weeks of treatment with a novel inhaled medication failed to improve exercise capacity, daily a
Trial for Gout Drug Meets Primary Endpoint, Raises Safety Concerns, image shows a CT scan showing gout in the knees.
News | ACC | March 20, 2018
March 20, 2018 — Febuxostat, a gout dr...
More Deaths, Strokes Seen with Perioperative Beta Blocker One Year After Surgery

Image from presentation, "1-Year outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery," Devereaux 

News | ACC | March 20, 2018
March 20, 2018 — During the 12 months after undergoing noncardiac surgery, patients with or at risk for heart disease
Canakinumab Doesn’t Prevent Prediabetes from Progressing to Diabetes according to a late-breaking study at ACC 2018.
News | ACC | March 20, 2018
March 20, 2018 — The anti-inflammatory...
Dabigatran Reduces Major Cardiovascular Complications in Patients With Myocardial Injury after Noncardiac Surgery
News | ACC | March 20, 2018
March 20, 2018 — Treatment with the blood-thinning drug dabigatran significantly reduced the risk of death, heart att
Statins May Bring Benefits at Time of Treatment for Heart Attack, Angina

Image from presentation, "Statins Evaluation in Coronary Procedures and Revascularization," Berwanger 

News | ACC | March 20, 2018
March 20, 2018 — Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broa
Overlay Init